The mission of CNICS is to provide access to the specimen and data repository to any investigator who submits an approved concept proposal. CNICS is a ‘peer-reviewed open access’ research platform available to investigators world-wide.
Upon submission of a concept study, the CNICS Administration will check for overlapping ideas or aims with an existing CNICS study to ensure each study has a unique data set without conflict. Should a new study be submitted that includes overlap, the CNICS Administration will work with researchers of both concepts to collaborate where research interests align.
CNICS has reviewed over 200 concept studies to date submitted by investigators at all levels, including graduate students, fellows, staff and faculty. These studies have resulted in over 350 peer reviewed manuscripts and over $125M in external funding awards to investigators working in CNICS, the majority of which are early career faculty and trainees.
| Concept Number | Title of Concept Study | Investigator(s) Name | Institute | Study Status |
| 001 | Impact of HAART and Metabolic Complications on Myocardial Infarction and Survival among HIV-infected Patients | Heidi Crane | University of Washington (UW) | Open |
| 002 | Incidence and Risk Factors for Triple Class Antiretroviral Regimen (ARV) Exposure and Failure in the CNICS Cohort | Richard Haubrich | University of California San Diego (UCSD) | Open |
| 003 | Biological and behavioral correlates of ART adherence and depression across diverse patients in the CNICS cohorts | Steven Safren | Fenway | Open |
| 004 | The incidence and correlates of HIV superinfection before starting and after stopping antiretroviral therapy | Davey Smith | University of California San Diego (UCSD) | Open |
| 005 | Viral Variation and the Development of Neutralizing Antibodies | Nancy L. Haigwood | University of Washington (UW) | Closed |
| 006 | gd-T cell Impairment and AIDS-associated Cancers | Richard Lopez | University of Alabama at Birmingham (UAB) | Closed |
| 007 | STI Burden and Behavioral Risks among HIV-infected Patients in Primary Care at CNICS collaborating sites | Kenneth Mayer | Fenway | Closed |
| 008 | Genetic variation and drug-drug interactions in tenofovir induced nephrotoxicity | Kathleen Giancomini | University of California San Francisco (UCSF) | Closed |
| 009 | Predictors of Severe Liver Enzyme Elevation and Immunologic Response to Initial HAART in Patients with HIV and Hepatitis Co-Infection | Chad Achenbach | Northwestern | Open |
| 010 | Eligibility for Early Initiation of Highly Active Antiretroviral Therapy (HAART) to Decrease HIV Transmission/ Julie Dombrowski UW | Julie Dombrowski | University of Washington (UW) | Open |
| 011 | Durability and Effectiveness of First-line ARV Regimens in treatment-naïve Patients Initiating Therapy in a Clinical Practice Setting | Michael Mugavero | University of Alabama at Birmingham (UAB) | Open |
| 012 | Association of cellular immune function and phenotype with severe liver enzyme elevation (LEE) after Highly Active Antiretroviral Therapy (HAART) among HIV and viral hepatitis co-infected patients | Chad Achenbach | Northwestern | Closed |
| 013 | Long-term virologic outcomes of HIV-infected patients coinfected with hepatitis B on tenofovir-containing HAART | Nina Kim | University of Washington (UW) | Open |
| 014 | Prevalence and associations of unprotected sex and substance use in the CNICS cohort | Matthew Mimiaga | Fenway | Open |
| 015 | Dynamic Assessment of Virologic Response and Mortality Among HIV-infected Patients Initiating Antiretroviral Therapy | Michael Mugavero | University of Alabama at Birmingham (UAB) | Open |
| 016 | An Analysis of Renal Function Before and After the Initiation of Highly Antiretroviral Therapy (HAART) to Examine Correlates of Renal Function Preservation and Decline | Robert Kalayjian | Case Western Reserve University (CWRU) | Open |
| 017 | HIV Pathogenesis and Immunity in Viremic Non-Progressors | David Camerini | University of California Irvine (UC Irvine) | Open |
| 018 | The Predictors of HIV+ smokers and investigation of smoking recognition and intervention by providers in two HIV ambulatory clinics | Karen Cropsey | University of Alabama at Birmingham (UAB) | Open |
| 019 | Molecular Epidemiology of HIV Transmission and Transmitted Resistance in Women and Minorities in the CNICS Cohort | Jeannette Aldous | University of California San Diego (UCSD) | Open |
| 020 | HIV infection in Sickle Cell Disease | Michael Lederman | Case Western Reserve University (CWRU) | Closed |
| 021 | Generalizing evidence from randomized clinical trials to target populations: the ACTG-320 trial | Steve Cole | University of North Carolina at Chapel Hill (UNC) | Open |
| 022 | Comparison of plasma HIV RNA with CD4+ T cell count-based strategies for detection of first line treatment failure and initiation of regimen modification | Maya Peterson | University of California Berkeley | Open |
| 023 | Measuring HIV transmission risk among HIV+ patients at CNICS sites | Joseph Schumacher | University of Alabama at Birmingham (UAB) | Open |
| 024 | AIDS-defining and non-AIDS defining malignancies among the CFAR Network of Integrated Clinical Systems (CNICS) | Michael Saag | University of Alabama at Birmingham (UAB) | Open |
| 025 | Effects of Hepatitis B co-infection on HIV Antiretroviral Therapy Response and Long-term Outcomes | Sarah Radke | University of North Carolina at Chapel Hill (UNC) | Open |
| 026 | Heterogeneity in Cytokine Responses to HIV-1 Infection | James Tang | University of Alabama at Birmingham (UAB) | Closed |
| 027 | Methods to migrate from the 9-item Patient Health Questionnaire (PHQ-9) to computerized adaptive administration of the Patient Reported Outcomes Measurement Information System (PROMIS) depression measur | Heidi Crane | University of Washington (UW) | Closed |
| 028 | HIV Infection and Response to Initial Therapy for Type 2 Diabetes | University of Pennsylvania (UPENN) | Open | |
| 029 | Contribution of enzyme (protease) and substrate (gag) mutations to protease inhibitor resistance | David Looney | University of California San Diego (UCSD) | Open |
| 030 | Epidemiology & Outcomes of HIV-2 in the United States | Geoffrey Gottlieb | University of Washington (UW) | Open |
| 031 | Adherence to Clinical Care and Survival among HIV-infected Patients Initiating Antiretroviral Therapy | Michael Mugavero | University of Alabama at Birmingham (UAB) | Open |
| 032 | HIV in the Elderly: Evaluating Indoleamine 2,3 dioxygenase as a marker for disease status | Stephanie Baer | Medical College of Georgia | Open |
| 033 | HIV-associated Obstructive Pulmonary Disease Examinations (HOPE): Risk, Exacerbations, and Outcomes | Kristina Crothers | University of Washington (UW) | Closed |
| 034 | Prognosis of incidence and progression risk of AIDS-defining and non-AIDS-defining malignancies in HIV/AIDS patients | Julia Krauchanka | Duke University | Open |
| 035 | Body morphology abnormalities and patient reported outcomes: depression, adherence, health-related quality of life, substance use, physical activity, and sexual risk behavior | Heidi Crane | University of Washington (UW) | Open |
| 036 | Routine Laboratory Monitoring During Virologically Suppressive Combination Antiretroviral Therapy in the US | Babafemi Taiwo | Northwestern | Open |
| 037 | Fine mapping of MHC susceptibility loci for AIDS-related non-Hodgkin lymphoma | Brahim Aissani | University of Alabama at Birmingham (UAB) | Open |
| 038 | The Timing of Antiretroviral Initiation among ART Naïve HIV Infected patients in routine clinical practice | Elvin Geng | University of California San Francisco (UCSF) | Open |
| 039 | Cross-walk between commonly used measures of anxiety in patients with HIV and the Patient Reported Outcomes Measurement Information System (PROMIS) anxiety measure | Heidi Crane | University of Washington (UW) | Open |
| 040 | Determinants of Transmitted Drug Resistance (TDR) and Impact of “Test and Treat” Strategy on Transmission of Drug Resistance Among HIV-1 Infected Treatment-Naïve Patients: Influence of High Risk Behaviors as Determined by Patient Based Metrics (PBM) on TDR Prevalence and Modeled Probability of Transmission | Vi Bowman | University of California San Diego | Closed |
| 041 | Systematic Characterization of High-Risk HPV Infection in Head and Neck Carcinoma in HIV+ Individuals | Margaret Brandwein-Gensler | University of Alabama at Birmingham | Open |
| 042 | Durability of initial compared to subsequent HAART regimens | Eric Sahloff | University of Toledo | Open |
| 043 | Comparing Results from Two Methods for Estimating the Optimal CD4 Threshold for Initiating Antiretroviral Therapy | Bryan Shephard | Vanderbilt University | Open |
| 044 | Biological Determinants of Long-term Immune Reconstitution following Combination Antiretroviral Therapy (cART) | Sharon Lewin | Monash University Australia | Open |
| 045 | BMI, Depression, and HIV Self-Care Behaviors among MSM | Aaron Blashill | Fenway | Open |
| 046 | Impact of presenting clinical features and subsequent treatment on outcomes after non-CNS HIV-associated lymphoma in the CNICS cohort | Satish Gopal | University of North Carolina at Chapel Hill (UNC) | Open |
| 047 | Time related factors of platelet count reduction in human immunodeficiency virus/HIV and Hepatitis C/HCV co-infected antiretroviral therapy/ARV Naiive patients | Chris Delaney | University of Florida | Closed |
| 048 | Structural models for exposure effects in HIV progression cohorts | Steve Cole | University of North Carolina at Chapel Hill (UNC) | Open |
| 049 | Effects of Combination Antiretroviral Therapy on Risk of Non-AIDS- defining Cancers | Elizabeth Yanik | University of North Carolina at Chapel Hill (UNC) | Closed |
| 050 | The Causal Effect of Antidepressant Treatment on HIV Outcomes in the CNICS Multi-Site Observational Clinical Cohort: An Application of Marginal Structural Models | Brian Pence | Duke University | Open |
| 051 | Risk Factors and microRNA Profiles of HIV Associated Lung Cancer | Kristina Crothers and Lynn Schnapp | University of Washington (UW) | Open |
| 052 | Molecular epidemiology of HIV transmission networks between Rhode Island and Massachusetts | Phillip Chan | Brown University | Open |
| 053 | Incidence and treatment of prostate cancer in HIV-infected men: do racial disparities exist? | Ramona Bhatia | Northwestern | Open |
| 054 | Impact of Transitioning from HIV Clinical Trials to Routine Medical Care on Virologic and Immunologic Outcomes | Baligh R. Yehia | University of Pennsylvania (UPENN) | Closed |
| 055 | Current practice of screening for incident HCV infection among HIV-infected individuals | Benjamin Linas | Boston Medical Center | Open |
| 056 | Evaluating the Relationship between HIV Transmission Networks in the San Diego-Tijuana Cross-Border HIV Epidemic and the Rest of the United States and the Difference between Geographically Localized and Geographically Diverse Transmission Networks | Sanjay Mehta | University of California San Diego (UCSD) | Open |
| 057 | The Natural History of Malignancies Developing Among HIV Positive Individuals on Stable Antiretroviral Therapy | Anna Coghill | University of Washington (UW) | Open |
| 058 | Endothelial Dysfunction, Antiretroviral Therapy, and Non-AIDS Defining Events in the CNICS Cohort | Susan Graham | University of Washington (UW) | Open |
| 059 | When to switch cART: A comparison of switching strategies using observational data | Lauren Cain | Harvard University | Open |
| 060 | Effects of Hepatitis C Co-infection on HIV Disease Progression and Long term Outcomes | Jennifer Ling | University of Washington (UW) | Closed |
| 061 | Frailty in HIV-infected older adults | Charles Kamen and Supriya Mohile | University of Rochester | Open |
| 062 | STI Screening and Determinants of Infection Among HIV-Infected Patients in Primary Care | Kenneth Mayer | Fenway | Open |
| 063 | Diagnosis and Treatment of Depression in HIV/AIDS Primary Care: A Comparative Analysis of Latino and Non-Latino White Patients | Oscar Beltran | University of Texas at El Paso (UTEP) | Open |
| 064 | Behavioral predictors of outcomes in HIV infected adolescents | Brian Zanoni | Massachusetts General Hospital, Fenway Community Health | Open |
| 065 | Optimal timing for starting cART in antiretroviral-naïve HIV-1–infected patients presenting with cryptococcal meningitis | Jonathan Sterne | University of Bristol | Open |
| 066 | Plasma cell neoplasms in HIV infected people: a multi center case series | Eric Engels | National Cancer Institute | Closed |
| 067 | Molecular profiling of HIV-associated lymphoma occurring before and during antiretroviral therapy | Satish Gopal | University of North Carolina at Chapel Hill (UNC) | Open |
| 068 | Alcohol Research Consortium in HIV – Epidemiological Research Arm (ARCH-ERA) U01AA020793 | Heidi Crane | University of Washington (UW) | Open |
| 068b | Alcohol Research Consortium in HIV: COVID Supplement | Heidi Crane | University of Washington (UW) | Open |
| 069 | Comparative effectiveness of SSRIs and SGAs among patients aging with HIV | Heidi Crane | University of Washington (UW) | Open |
| 070 | OMCICH: Optimal Multidisciplinary Care in the Clinical HIV Setting | Michael Horberg | Mid-Atlantic Kaiser Permanente Group | Open |
| 071 | Factors that influence the response to Hepatitis A vaccine among HIV-infected individuals | Heidi Crane | University of Washington (UW) | Open |
| 072 | Statins in HIV: Immune Reconstitution, Comorbid Events, and Survival | Dan Drozd | University of Washington (UW) | Open |
| 073 | Epidemiology of Cerebrovascular Disease in CNICS | David Tirschwell | University of Washington (UW) | Open |
| 074 | Race-specific association between CCR5 -2459G>A genotype and virologic response to HAART in the CNICS cohort | Rajeev Mehlotra | Case Western Reserve University (CWRU) | Closed |
| 075 | Modeling the dynamic association of BMI and mortality in HIV positive adults | Jianghua He | University of Massachusetts (UMASS) | Closed |
| 076 | Relationship of virologic suppression and control of cardiometabolic comorbidities in HIV-infected patients on antiretroviral therapy | Greer Burkholder | University of Alabama at Birmingham (UAB) | Open |
| 077 | Incidence and treatment of anal cancer in HIV-infected individuals: do racial/ethnic disparities exist? | Candice McNeil | Stanford University | Open |
| 078 | Hepatitis C treatment uptake and predictors of HCV therapy among HIV-infected individuals in the era of direct-acting antiviral agents | Ed Cachay | University of California San Diego (UCSD) | Open |
| 079 | Sero-incidence of Herpes Simplex Virus Types 1 and 2 in HIV-infected persons receiving HIV-care | Nicholas Van Wagoner | University of Alabama at Birmingham (UAB) | Closed |
| 080 | Circulating MicroRNAs in HIV-infected Patients with and without Coronary Artery Disease | Venkata Narla and Priscilla Hsue | University of California San Francisco | Open |
| 081 | Understanding Patient Populations Receiving Antiretroviral Therapy: Observational Channeling Bias Study | Michael Saag, Steve Cole and Andy Westfall | University of Alabama at Birmingham (UAB) & University of North Carolina at Chapel Hill (UNC) | Open |
| 082 | Assessment of Markers of Microbial Translocation, Gut Mucosal Integrity, and Inflammation in HIV-infected Patients with Delayed Vs. Normal Immune Recovery on Suppressive Antiretroviral Therapy | Gregory Huhn, Peter Hunt and Bellur Prabhakar | Chicago Cook County Hospital | Open |
| 083 | Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi’s Sarcoma Who Do Not Have Urgent Indications for Chemotherapy | Jackie Wang | University of California San Francisco (UCSF) | Closed |
| 084 | Selection bias due to restriction in cohort studies | Chanelle Howe | Brown University | Open |
| 085 | Antiretroviral switches in HIV/HCV co-infected patients: Initiating direct acting antiviral therapies for Hepatitis C Infection | Julius Wilder and Susanna Naggie | Duke University | Open |
| 086 | HIV-related Health Disparities in Latinos Living with HIV in the United States | John Sauceda | University of California San Francisco | Open |
| 087 | When to monitor: A comparison of immunologic and virologic monitoring strategies using observational data | Ellen Caniglia | Harvard University | Open |
| 088 | Differential Virologic and Resistance Outcomes when using Efavirenz-based Single Tablet Regimens versus Multiple Tablet Regimens in HIV Treatment | Michael Saag and Andy Westfall | University of Alabama at Birmingham (UAB) | Open |
| 089 | Calcium antagonist and CVD risk among hypertensive HIV+ patients | Sadeep Shrestha | University of Alabama at Birmingham (UAB) | Closed |
| 090 | Identify and Manage Promptly Incident Hepatitis C: Testing to Treatment in HIV (IMPACT-C) | Benjamin Linas and Lynn Taylor | Boston Medical Center | Closed |
| 091 | Preventive fractions of Kaposi sarcoma and non-Hodgkin lymphoma in the modern ART era | Elizabeth Yanik | National Cancer Instittute | Open |
| 092 | Application of the Updated ACC/AHA Atherosclerotic CVD Risk Assessment Tool and Prevention Guidelines Among HIV-Infected Individuals: CFAR Network of Integrated Clinical Systems (CNICS) | Matthew Feinstein | Northwestern | Open |
| 092a | Performance of the American Heart Association’s PREVENT Risk Calculator for People with HIV | Matt Durstenfeld | University of California San Francisco (UCSF) | Open |
| 093 | Analysis of CNICS data to inform design of interventions to enhance HIV care among substance abusers | Bryan Hartzler | University of Washington (UW) | Open |
| 094 | Population interventions on smoking in the CNICS/ Bryan Hartzler UW | Bryan Hartzler | University of Washington (UW) | Open |
| 095 | Factors Associated with HAART Medication Adherence among Older Adults Living with HIV in the U.S. | Brian Witt | University of North Carolina at Chapel Hill (UNC) | Closed |
| 096 | The Affordable Care Act, Socioeconomic Context, Spatial Mapping, and Outcomes Among People Living With HIV | Aadaora Adimora | University of North Carolina at Chapel Hill (UNC) | Open |
| 097 | Pathways contributing to racial and economic disparities among HIV clinic cohort patients | Chanelle Brown | Brown University | Closed |
| 098 | Genomic approaches to cardiometabolic risk and treatment in HIV | Inga Peter | Mount Sinai | Open |
| 099 | Investigating the relationship between chronic pain and HIV outcomes | Jessie Merlin | University of Alabama at Birmingham (UAB) | Open |
| 100 | Cardiovascular, pulmonary, and hematological disease in HIV: Prevention and Treatment | Heidi Crane | University of Washington (UW) | Open |
| 101 | Statin use among HIV-infected patients | Greer Burkholder | University of Alabama at Birmingham (UAB) | Open |
| 102 | Comparative Effectiveness of Single-Action verses Multi-Action Antidepressants on Depression, Treatment Adherence and HIV Clinical Outcomes among People Living with HIV/AIDS and Depression | Jon Mills | University of North Carolina at Chapel Hill (UNC) | Open |
| 103 | Development and Validation of a Multidimensional Index of Engagement in HIV Care | Kristian Christopoulos and Mallory Johnson | University of California San Francisco (UCSF) | Open |
| 104 | Calibration of a 1-Year Virologic Prediction Rule for Race/Ethnicity and Gender. | Gregory Robbins | Mass Gen/ Harvard University | Open |
| 105 | The HIV Care Continuum: CD4 and Viral Load Measures as Proxies for Routine HIV Care Visits | Kimberly Powers | University of North Carolina at Chapel Hill (UNC) | Open |
| 106 | Diminishing “Clinic Viral Load” in CNICS clinics in the U.S.: Socio-demographic and Therapeutic Correlations with Adherence | Jane Simoni | University of Washington (UW) | Open |
| 107 | The CD4/CD8 ratio as a predictor of adverse outcomes in HIV-infected subjects under suppressive antiretroviral therapy and elite controllers | Sergio Serrano-Villar | University Hospital Ramón y Cajal- Madrid, Spain | Open |
| 108 | Modeling Depression Treatment Strategies for Human Immunodeficiency Virus (HIV) Positive Patients | Rongbing Xie | University of Alabama at Birmingham (UAB) | Open |
| 109 | Physical activity patterns and metabolic disease outcomes in people living with HIV | Amanda Willig | University of Alabama at Birmingham (UAB) | Open |
| 110 | Projected Burden of Chronic Disease within the PLWH Population | Julia Hood | University of Washington (UW) | Open |
| 111 | Impact of low-level HIV viremia on cancer risk | Jennifer Lee | University of North Carolina at Chapel Hill (UNC) | Open |
| 112 | A statistical framework for integrated analysis of the HIV care cascade using CNICS data | Hanna Lee | Brown University | Open |
| 113 | What to start: co-formulated versus individual tablets regimens in high-income countries | Sarah Lodi | Harvard University | Closed |
| 114 | Self-management and quality of life in persons with HIV and diabetes, a comparison study. | Julie Zuniga | University of Texas Austin | Open |
| 115 | Lipidomic Profiling in HIV patients newly initiating antiretroviral treatment | Ryan Irvin | University of Alabama at Birmingham (UAB) | Open |
| 116 | Identification of Novel Metabolic Biomarkers for Predicting Cardiovascular Events in Persons Living with HIV | Svati Shah | Duke University | Open |
| 117 | Supplement to Approved CP 103: Development and Validation of a Multidimensional Index of Engagement in HIV Care | Kristina Christopoulos and Mallory Johnson | University of California San Francisco (UCSF) | Closed |
| 118 | Efavirenz and the risk of suicidality | Angela Bengston | University of North Carolina at Chapel Hill (UNC) | Open |
| 119 | Age and Risk of HAART-Associated Nephrotoxicity: a Retrospective Cohort Study | Jessie Torgersen | Hospital of the University of Pennsylvania | Open |
| 120 | Pathways contributing to racial/ethnic disparities among HIV clinic cohort patients | Chanelle Howe | Brown University | Open |
| 121 | Combined when to start analyses of the START trial, HIV-CAUSAL and CNICS | Steve Cole | University of North Carolina at Chapel Hill (UNC) | Closed |
| 122 | At-Risk Alcohol Use and the Completion of Patient Reported Outcomes | Jacquelin Rudolph | University of North Carolina at Chapel Hill (UNC) | Open |
| 123 | Examining causes of death among patients with HIV in the United States: methodologic tools and applications | Jess Edwards | University of North Carolina at Chapel Hill (UNC) | Open |
| 124 | Health Outcomes Among Transgender Patients in HIV Care: Findings from the CNICS Cohort | Sari Reisner | Fenway | Open |
| 125 | Durability of Contemporary Antiretroviral Regimens in Treatment Naïve Persons living with HIV | Ellen Eaton | University of Alabama at Birmingham (UAB) | Open |
| 126 | Phylogeographic approach to determine the dynamics of HIV in circulating cellular reservoirs during ART failure and after re-suppression. | Antoine Chaillon | University of California San Diego (UCSD) | Closed |
| 127 | Kidney Failure Risk Projection for the HIV-infected Living Kidney Donor Candidate | Jayme Locke | University of Alabama at Birmingham (UAB) | Open |
| 128 | The Syndemics of Aging with HIV | Maile Karris | University of California San Diego (UCSD) | Closed |
| 129 | Hemoglobin as a criterion to switch antiretroviral therapy in HIV-positive individuals | Lauren Cain | Harvard University | Open |
| 130 | Comparative effectiveness of integrase-inhibitor-based regimens versus NNTRI- and boosted-PI-based regimens. | Steve Cole | University of North Carolina at Chapel Hill (UNC) | Open |
| 131 | Patient-reported sexual risk behavior and viral suppression over time | Julia Raifman | Johns Hopkins Bloomberg School of Public Health | Open |
| 132 | Comparing Duraility, Treatment Failure and Emergence of Resistance on Integrase Stand Transfer Inhibitor Treatment Regimens Among Treatment-Naïve and Treatment-Experienced Patients with HIV (UAB Protocol # X151228001) | Heidi Crane | University of Washington (UW) | Open |
| 133 | A Feasibility and Pilot Study of Clinical Outcomes among Transgender Women Living with HIV | Tonia Poteat | Johns Hopkins Bloomberg School of Public Health | Open |
| 134 | The impact of substance use on health outcomes over time among persons living with HIV | W. Scott Comulada | University of California Los Angeles (UCLA) | Closed |
| 135 | The Joint Effects and Plausible Interventions for ART and Statin Use on Mortality | Jonathan Post | University of North Carolina at Chapel Hill (UNC) | Closed |
| 136 | Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits | April Pettit | Vanderbilt University | Open |
| 137 | Physical Activity and Symptom Distress in HIV+ Adults in the CNICS Database | Allison Webel | Case Western Reserve University | Open |
| 138 | Statin use to prevent progression of liver disease among HIV infected individuals | Bryan Lau | Johns Hopkins University | Open |
| 139 | Real World Effectiveness of Direct-Acting Antiviral Agents for Hepatitis C Infection Among HIV/HCV-Coinfected Patients | Nina Kim | University of Washington (UW) | Open |
| 140 | Cigarette Smoking and HIV Treatment Outcomes Among MSM in Primary Care | Conall O'Cleirigh | Harvard University | Open |
| 141 | Epidemiology of Heavily Treatment-Experienced (HTE) HIV Patients in the US | Michael Saag and Ellen Eaton | University of Alabama at Birmingham (UAB) | Open |
| 142 | Development and Validation of Risk Prediction Model for End Stage Liver Disease and Hepatocellular Carcinoma in Persons living with HIV | Nina Kim | University of Washington (UW) | Open |
| 143 | Evaluation of the efficacy, mechanism, and cost-effectiveness of Skills TO Manage Pain (STOMP), a novel group and peer-based behavioral intervention for chronic pain tailored to people living with HIV | Jessie Merlin | University of Alabama at Birmingham (UAB) | Open |
| 144 | Rates and Predictors of Bacterial STI in Women with HIV | Jodie Dionne-Odom | University of Alabama at Birmingham (UAB) | Open |
| 145 | Diabetes as a risk factor for tuberculosis in HIV positive individuals in the United States | Kristina Bajema | University of Washington (UW) | Closed |
| 146 | A personalized approach to mental health in HIV | Todd Fojo | Johns Hopkins University | Open |
| 147 | Epidemiology of HIV-related atrial fibrillation and associations with substance abuse | Susan Heckbert | University of Washington (UW) | Open |
| 148 | Estimating the potential pool of HIV-infected deceased organ donors in the United States | Jayme Locke | University of Alabama at Birmingham (UAB) | Open |
| 149 | Primary Infection Resource Consortium (PIRC) | Susan Little | University of California San Diego (UCSD) | Closed |
| 150 | Patterns and Perceptions of e-Cigarettes and Vaporized Nicotine Among People Living with HIV | Rob Fredericksen | University of Washington (UW) | Closed |
| 151 | Longitudinal HIV Care Trajectories and HIV Transmission Risk from the Time of HIV Care Entry in the CNICS | Kimberly Powers | University of North Carolina at Chapel Hill (UNC) | Open |
| 152 | Condom-less sex behavior and health outcomes among HIV-infected patients in the PrEP era | Rob Fredericksen | University of Washington (UW) | Open |
| 153 | Patient Usability and Acceptability of Electronic Patient-Reported Outcome Measures for Use in HIV Care | Rob Fredericksen | University of Washington (UW) | Closed |
| 154 | Plasma IL-6 signaling biomarkers and cardiovascular disease in the CNICS cohort | Lee Sulggi | University of California San Francisco (UCSF) | Closed |
| 155 | HIV/HCV Coinfection and Incidence of Extrahepatic Cancers | Julia Marcus | Harvard University | Open |
| 156 | Predictive Analytics for Retention in HIV Care | Jessica Ridgway | University of Chicago | Open |
| 157 | Understanding the effect of physical activity and dietary intake on the longitudinal symptom experience of HIV+ adults in the CNICS cohort | Allison Webel and Amanda Willig | Case Western Reserve University (CWRU) & University of Alabama at Birmingham (UAB) | Open |
| 157a | Examining HIV-related Symptom Moderation of the Executive Function/Self-Management Process | Nathaniel Schreiner | Case Western Reserve University (CWRU) | Open |
| 158 | Preparing for Long-Acting Injectable ART: Patient and Provider Perceptions, Preferences, and Shared Decision-Making | David Wohl | University of North Carolina at Chapel Hill (UNC) | Open |
| 159 | Health Outcomes among Patients in HIV Care Reporting Intimate Partner Violence | Rob Fredericksen | University of Washington (UW) | Open |
| 160 | Impact and Correlates of Sub-Optimal Social Support Among Patients in HIV Care | Rob Fredericksen | University of Washington (UW) | Open |
| 161 | Health Disparities and Social Determinants for HIV-Associated Neurocognitive Disorders and its Risk Factors | Pariya Fazeli Wheeler | University of Alabama at Birmingham (UAB) | Open |
| 162 | Viral suppression and sexual risk among people living with HIV: potential impact of risk compensation on HIV transmission | Heather Pines | University of California San Diego (UCSD) | Open |
| 163 | Improving Kidney Health for African Americans with HIV through Optimal Antiretroviral Therapy Selection | Ellen Eaton | University of Alabama at Birmingham (UAB) | Open |
| 164 | Role of medication assisted treatment on HIV treatment outcomes among opioid and stimulant users | Javier Cepeda | University of California San Diego (UCSD) | Open |
| 165 | Effectiveness of second-line antiretroviral therapy | Thibaut Davy-Mende | University of North Carolina at Chapel Hill (UNC) | Open |
| 166 | Genes, substance use, and HIV outcomes in people living with HIV across the US | Heidi Crane | University of Washington (UW) | Open |
| 167 | Interventions to prevent cardiovascular disease among people living with HIV | Alexander Breskin | University of North Carolina at Chapel Hill (UNC) | Closed |
| 168 | Characterization of Symptom Clusters Among People Living With HIV Disease | Natalie Wilson | University of California San Francisco (UCSF) | Open |
| 169 | Effectiveness of a smoking cessation algorithm integrated into HIV primary care. | Karen Cropsey | University of Alabama at Birmingham (UAB) | Closed |
| 170 | Determinants and Outcomes of Nicotine Metabolism in HIV | Robert Gross | University of Pennsylvania (UPENN) | Open |
| 171 | Marijuana policy change impact on patterns of marijuana and other harmful substance use among people living with HIV: a mixed methods evaluation | Andrew Hahn | University of Washington (UW) | Open |
| 172 | Prevalence and Risk Factors for Hepatitis Delta Infection Among a Cohort of HIV/Hepatitis B-Coinfected Patients in the United States | Vincent Lo Re | University of Pennsylvania (UPENN) | Closed |
| 173 | Optimizing the Implementation of the U=U Strategy for HIV Prevention in Clinic Settings | Curt Beckwith | Brown University | Open |
| 174 | Substance use and risk of stroke among people living with HIV | Thomas Martin | University of California San Diego (UCSD) | Closed |
| 175 | Host genetics and risk of anal cancer among patients living with HIV | Helen Stankiewicz Karit | University of Washington (UW) | Open |
| 176 | Genetic predictors of adiposity-related traits including body mass index, lipoatrophy, lipohypertrophy and ART treatment-induced obesity among people living with HIV | Sara Lindstroem | University of Washington (UW) | Open |
| 177 | Gender Identity and Participation in Biomedical Research | April Pettit | Vanderbilt University | Open |
| 178 | Differences in substance use patterns among people living with HIV by geographic region | Heidi Crane | University of Washington (UW) | Closed |
| 179 | Mental health, alcohol, and other substance use disorders Prevalence, co-occurrence and durability of symptoms; pharmacologic treatment initiation and retention; and impact of treatment on retention in HIV care and viral suppression | Catherine Lesko | Johns Hopkins University | Open |
| 180 | Factors associated with Initiating Care for Vulnerable HIV-Infected Individuals with Substance Use | Canada Parrish | University of Washington (UW) | Closed |
| 181 | Evaluating the impact of food insecurity on diabetes risk and treatment outcomes among adults with HIV+ in the PROSPER-HIV study | Allison Webel and Amanda Willig | Case Western Reserve University (CWRU) & University of Alabama at Birmingham (UAB) | Open |
| 182 | Machine learning to identify persons at high-risk of disengaging from HIV care in the United States | Sahar Saeed | Washington University in St. Louis | Open |
| 183 | Impact of COVID-19 among people living with HIV in the CNICS cohort: overall and symptomatic incidence, predictors of disease, adverse clinical outcomes, and mortality | Ed Cachay, Lalo and Adrienne Shapiro | University of Washington (UW) | Closed |
| 184 | Impact of FUT2 Genetic Variability on HIV-associated Inflammation. | Mohamed Abdel-Mohsen | Wistar Institute | Open |
| 185 | Quality of life validation studies in CNICS | Heidi Crane | University of Washington (UW) | Open |
| 186 | Impact of childhood abuse on health outcomes among patients living with HIV | Rob Fredericksen | University of Washington (UW) | Open |
| 187 | Burden of Morbidity and Premature Mortality in patients with HIV-associated Malignancies | Guarav Goyal | University of Alabama at Birmingham (UAB) | Open |
| 188 | Antiretroviral Utilization in the Current Treatment Era (2018-2020) | Jimmy Ma | University of Washington (UW) | Closed |
| 189 | Patient Perceptions of the Impact of the SARS-CoV-2 pandemic: Impact on patient reported outcomes and HIV-related outcome disparities | Mallory Johnson | University of California San Francisco (UCSF) | Open |
| 190 | Trauma and adherence: A lifecourse approach to understanding HIV in older adults | Paul Nash | University of Southern California | Open |
| 191 | A cross sectional analysis of psychological stress, physical activity, and viral suppression as predictors of Cardiovascular Disease risk in older persons with HIV | Crista Irwin | Emory University | Open |
| 192 | Mentoring Patient-Oriented Research on Advances to Optimize Engagement in HIV Care | Katerina Christopoulos | University of California San Francisco (UCSF) | Open |
| 193 | Relationship between body fat and functional status among adults aging with HIV | Vitor Oliveira | Case Western Reserve University | Closed |
| 194 | Deep Phenotyping of HIV-Related Heart Failure | Matthew Feinstein | Northwestern | Open |
| 195 | Internalized HIV Stigma and Viral Suppression: Examining the Mediating and Moderating Roles of Social Support, Substance Use, and Depressive Symptoms | Timothy Crawford | Wright State University Boonshoft School of Medicine | Open |
| 196 | Psychosocial Effects of HIV Nondisclosure Laws Among People Living with HIV | Steve Safren | University of Miami | Open |
| 197 | Changes in weight after switching off of integrase strand transfer based regimens does the next regimen matter | Jeff Yin | University of California San Diego (UCSD) | Closed |
| 198 | Determination of the Impact of Abnormal Glucose Levels on Progression to Frailty Among People Living with HIV | Andrew Hahn | University of Washington (UW) | Open |
| 199 | Social Determinants of Health Disparities and Multiple Co-morbidities among Men and Women Living with HIV | Jenni Wise | University of Alabama at Birmingham (UAB) | Open |
| 200 | Examining influences on physical activity behaviors and quality of life among adults living with HIV | Sable Watson | University of North Carolina at Chapel Hill (UNC) | Open |
| 201 | Host Genetic Predictors of Vascular Complications: A CNICS Mendelian Randomization Study | Sulggi Lee | University of Chicago | Closed |
| 203 | Impact of ongoing COVID-19 pandemic on people with HIV in the US | Adrienne Shapiro | University of Washington (UW) | Open |
| 204 | Cardiometabolic Disease Among Frailty Clusters in Adults Aging with HIV | Raymond Jones | University of Alabama at Birmingham (UAB) | Open |
| 205 | Understanding Racial and the Social Determinants of Disparities in Depression and Non-Communicable Disease Outcomes in Adults Living with HIV | Aima Ahonkhai | Vanderbilt University | Open |
| 206 | Effect of Internalized HIV Stigma on Cardiovascular Disease Risk in Women Living with HIV | Jess Sherman | Ohio State University | Open |
| 207 | Impact of depression and HIV symptoms on glycemic outcomes (A1c, BG) among patients living with HIV and type 2 diabetes. | Veronica Brady | University of Texas Health Science Center at Houston | Open |
| 208 | Role of integrase strand transfer based regimens in people with HIV and hypertension | Mohammed Siddiqui | University of Alabama at Birmingham (UAB) | Open |
| 209 | Internalized HIV Stigma, Age and Gender related outcomes among people with HIV (HIV StAGe Outcomes) | Lydia Drumright | University of Washington (UW) | Open |
| 210 | Epidemiology of monkeypox among people with HIV in the CNICS cohort: incidence, clinical outcomes, access to treatment, and predictors of disease acquisition and severity | Michalina Montano | University of Washington (UW) | Open |
| 211 | Identifying genetic contributors for cardiovascular disease with people with HIV-infection | Nicole Armstrong | University of Alabama at Birmingham (UAB) | Open |
| 212 | Aging, Depressive Symptoms, Antidepressant Effectiveness, and Incidence of Stroke among People with HIV | Jimmy Ma | University of Washington (UW) | Open |
| 213 | Alcohol Research Consortium in HIV – Epidemiological Research Arm from P01 AA029544 | Heidi Crane | University of Washington (UW) | Open |
| 214 | Re-demonstrating the clinical relevance of retention in care: A longitudinal multisite analysis of two cohorts | Emma Kay | Birmingham AIDS Outreach (BAO) | Open |
| 215 | Characterization and Clustering of Symptoms in People with HIV | Tru Cao | University of Texas Health Science Center at Houston | Open |
| 216 | Type 1 Hybrid Effectiveness-Implementation Trial of a Digital Therapeutic for Smoking Cessation Tailored to Persons Living with HIV | Roger Villardaga | Wake Forest University University of Buffalo | Open |
| 217 | Human monkeypox (MPX) vaccination among men who have sex with men (MSM) and/or transgender women in the CNICS cohort: vaccine uptake and hesitancy beliefs | Rob Fredericksen | University of Washington (UW) | Open |
| 219 | Renewal application: Impact of Physical Activity Routines and Dietary Intake on the Longitudinal Symptom Experience of the people living with HIV (PROSPER-HIV 2) | Allison Webel and Mandy Willig | University of Alabama at Birmingham (UAB) | Open |
| 220 | Evaluating Risk Factors and Prevalence of Hepatitis C Viremia among People with HIV in the Direct Acting Antiviral Era | Jimmy Ma | University of Washington (UW) | Open |
| 221 | Antibiotics for Treatment of Methamphetamine Use Disorder Among People Living with HIV | Aurelio Galli | University of Alabama at Birmingham (UAB) | Open |
| 222 | Evaluating the impact of genital STI diagnosis on incidence of HCV infection in PWH | Yotam Arens | University of Pennsylvania (UPENN) | Open |
| 223 | Behavioral health characteristics related to adherence in PLWH | Cristina Lopez | Medical University of South Carolina (Charleston SC) | Open |
| 224 | Eicosanoids as Novel Inflammatory Mediators of CVD in Men and Women with HIV | Claudia Martinez | University of Miami | Open |
| 225 | Innovative Computational Tools and Best Practice Recommendations for Analyzing HIV-related Count Outcomes | David Huh | University of Washington (UW) | Open |
| 226 | Malignancy incidence and phenotype following acute cardiovascular events in CNICS | Matthew Feinstein | Northwestern | Closed |
| 227 | Elucidating Genetic Risk Factors for AKI and AKI-related Outcomes among People with HIV | Molly Fisher | Albert Einstein College of Medicine, Montefiore Medical Center | Open |
| 228 | Addressing Barriers to the Comprehensive Use of Statins in people with HIV: the ABACUS-HIV study | Thibaut Davy-Mendez | University of North Carolina at Chapel Hill (UNC) | Open |
| 229 | Impact of New Antidiabetic Medications Among People with HIV | Sherif Eltonsy | University of Manitoba | Open |
| 230 | Associations Between Chronic Kidney Disease (CKD) and Substance Use, Hypertension, Insomnia, and Diabetes Among PWH | Chris Delaney | University of Washington (UW) | Open |
| 231 | Exploration of Depressive Symptoms in the Diagnosis of Type 2 Diabetes in People Living with HIV | Shelagh Mulvaney | Vanderbilt University | Open |
| 232 | Frailty and frailty transitions in aging persons with HIV: are they associated with serum miRNA profiles? | Lee D Chaves | University of Kansas Medical Center | Open |
| 233 | Syndemic Trajectories among Gay, Bisexual, and Other Men Who Have Sex with Men living with HIV in the U.S. | Pablo Valente | University of Connecticut (UConn) | Open |
| 234 | Prediction of Hepatocellular Carcinoma Risk in HIV/HBV Coinfected Individuals of Black/African Ethnicity and Other Populations in the CNICS Cohort using the PAGE-B and mPAGE-B Scores | George Yendewa | Case Western Reserve University | Open |
| 235 | Enhance Social Support for Black Women with HIV Using Technology | Crystal Chapman Lambert | University of Alabama at Birmingham (UAB) | Open |
| 236 | Lung cancer prediction and outcomes model for people living with HIV (R01 proposal) | Kristina Crother | University of Washington (UW) | Open |
| 237 | Exploring the Potential for Psychedelics to Reduce HIV Infections and Improve Health and Wellbeing in Gay, Bisexual, and Other Cisgender Men Who Have Sex with Men in the US | Nic Carlisle | University of Alabama at Birmingham (UAB) | Open |
| 238 | Association of 1991 birth-dose Hepatitis B Virus (HBV) vaccination policy in the United States and HBV prevalence among PWH enrolled in HIV care | Tarfa Verinumbe | Johns Hopkins University | Open |
| 239 | HIV, Comorbidities, and Behavioral Health Outcomes by Neighborhood Physical and Social Environments through Geocoded Variables | Carolyn Fahey | University of Washington (UW) | Open |
| 240 | Ubiquitin D (UBD) variants and CKD outcomes in persons with HIV | Michael Ross | Albert Einstein College of Medicine | Open |
| 241 | Centering HIV Stigma in Clinical Conversations to increase Alcohol Treatment Uptake (CHAT) | Elizabeth Austin | University of Washington (UW) | Open |
